Gene · 8205
Papers2,064
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,064
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ncRNA-Regulated LAYN Serves as a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Hepatocellular Carcinoma: A Bioinformatics Analysis. | Biomed Res Int | 2022 | 36398067 | PubTator, text mining | PubMed |
| Stress in surgical educational environments: a systematic review. | BMC Med Educ | 2022 | 36380334 | PubTator, text mining | PubMed |
| TMPRSS4 is a novel biomarker and correlated with immune infiltration in thyroid carcinoma. | BMC Endocr Disord | 2022 | 36380313 | PubTator, text mining | PubMed |
| Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancer. | Cancer Cell Int | 2022 | 36369058 | PubTator, text mining | PubMed |
| Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests. | Int J Mol Sci | 2022 | 36362392 | PubTator, text mining | PubMed |
| Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs. | Int J Mol Sci | 2022 | 36362222 | PubTator, text mining | PubMed |
| The Ion Channel Gene KCNAB2 Is Associated with Poor Prognosis and Loss of Immune Infiltration in Lung Adenocarcinoma. | Cells | 2022 | 36359834 | PubTator, text mining | PubMed |
| Self-Renewal of Macrophages: Tumor-Released Factors and Signaling Pathways. | Biomedicines | 2022 | 36359228 | PubTator, text mining | PubMed |
| Preclinical characterization and phase I clinical trial of CT053PTSA targets MET, AXL, and VEGFR2 in patients with advanced solid tumors. | Front Immunol | 2022 | 36341335 | PubTator, text mining | PubMed |
| GLI1+ cells are a source of repair-supportive mesenchymal cells (RSMCs) during airway epithelial regeneration. | Cell Mol Life Sci | 2022 | 36333491 | PubTator, text mining | PubMed |
| Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment. | Nat Commun | 2022 | 36333338 | PubTator, text mining | PubMed |
| Pleiotropic effects of antibiotics on T cell metabolism and T cell-mediated immunity. | Front Microbiol | 2022 | 36329851 | PubTator, text mining | PubMed |
| CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer. | BMC Med Genomics | 2022 | 36316684 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals the relationship between RCSD1 immune infiltration and clinical prognosis in human tumors. | Front Immunol | 2022 | 36311703 | PubTator, text mining | PubMed |
| Targeting tumor-associated macrophages for the immunotherapy of glioblastoma: Navigating the clinical and translational landscape. | Front Immunol | 2022 | 36311702 | PubTator, text mining | PubMed |
| New soliton molecules to couple of nonlinear models: ion sound and Langmuir waves systems. | Opt Quantum Electron | 2022 | 36311163 | PubTator, text mining | PubMed |
| Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer. | Front Bioinform | 2022 | 36304286 | PubTator, text mining | PubMed |
| Integrative genomic analysis facilitates precision strategies for glioblastoma treatment. | iScience | 2022 | 36300002 | PubTator, text mining | PubMed |
| A Journey to the Central Nervous System: Routes of Flaviviral Neuroinvasion in Human Disease. | Viruses | 2022 | 36298652 | PubTator, text mining | PubMed |
| Nanoparticle-Based Drug Delivery Systems Targeting Tumor Microenvironment for Cancer Immunotherapy Resistance: Current Advances and Applications. | Pharmaceutics | 2022 | 36297426 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8205/papers?page=27